Mackenzie Financial »

Amylyx Pharmaceuticals shares owned by Mackenzie Financial

Quarter-by-quarter ownership of Amylyx Pharmaceuticals (AMLX) shares owned by Mackenzie Financial from 13F filings

Historical chart of Mackenzie Financial investment in Amylyx Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Amylyx Pharmaceuticals held by Mackenzie Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amylyx Pharmaceuticals by Mackenzie Financial

Quarter filed Position value Share count Share price at filing
2024-03-31 $206k 73k 2.84

More positions owned by Mackenzie Financial

Rbc Cad (RY)
Microsoft Corporation (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Toronto Dominion Bk Ont Com New (TD)
Bank Of Montreal Cadcom (BMO)
Canadian Natl Ry (CNI)
Canadian Pacific Kansas City (CP)
Canadian Natural Resources (CNQ)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Visa Com Cl A (V)
Aon Shs Cl A (AON)
Amazon (AMZN)
Telus Ord (TU)
Stantec (STN)

View all positions for Mackenzie Financial

Top funds holding Amylyx Pharmaceuticals

Vanguard Group
BlackRock
Goldman Sachs Group
Millennium Management
Citadel Advisors
Morgan Stanley
Perceptive Advisors
Franklin Resources
Ikarian Capital
Boxer Capital
Susquehanna International
Two Sigma Investments
Farallon Capital Management
Geode Capital Management
D. E. Shaw & Co

View all funds holding Amylyx Pharmaceuticals